• In April 2026, Aehr Test Systems reported a record US$41 million production order from a major hyperscale AI customer and a year-over-year jump in its unfilled order backlog to US$38.70 million, even as it completed an at-the-market equity program and posted a quarterly loss on weaker revenue.
• This combination of large AI-related orders, growing backlog, fresh equity capital, and recent insider selling highlights both the company’s expanding opportunities in semiconductor burn-in technology and the tensions around funding growth and shareholder dilution.
• With this backdrop and strong AI-driven order growth, we’ll examine how the record hyperscale customer win shapes Aehr Test Systems’ investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

What Is Aehr Test Systems' Investment Narrative?

To own Aehr Test Systems, you have to believe that wafer-level burn-in becomes a must-have step in advanced chip production, particularly for AI and data center workloads, and that Aehr can convert early wins into a broader, stickier customer base. The record US$41 million hyperscale AI order and the jump in backlog look like validation of that thesis, but they sit alongside shrinking recent revenue, ongoing losses, heavy insider selling and a very high price-to-book multiple. The fresh US$60 million equity raise and at-the-market program give Aehr more capacity to fulfill large orders, yet they also highlight dilution risk just as the share price has been extremely volatile. In the near term, execution on this hyperscale order and any follow-on wins are likely to be key catalysts.

However, recent share issuance and insider selling are signals investors should understand before getting comfortable. The analysis detailed in our Aehr Test Systems valuation report hints at an inflated share price compared to its estimated value.

Exploring Other Perspectives

Investors in the Simply Wall St Community put Aehr’s fair value anywhere from US$14.27 to US$63.67 across six views, underscoring how differently people weigh a record AI order against ongoing losses and dilution risk. This spread invites you to compare your own expectations about burn-in adoption and contract execution with a wide set of alternative assumptions.

Explore 6 other fair value estimates on Aehr Test Systems - why the stock might be worth as much as $63.67!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Aehr Test Systems research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Aehr Test Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Aehr Test Systems' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find 51 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.